Compare Adaptive Biotechnologies Corp (ADPT) vs American Homes 4 Rent Class A (AMH) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs American Homes 4 Rent Class A — how do they compare? Adaptive Biotechnologies Corp trades at $19.89 (market cap $3.33B), while American Homes 4 Rent Class A trades at $33.4 (market cap $12.23B). The key difference: American Homes 4 Rent Class A is far larger — about 3.7× Adaptive Biotechnologies Corp's market cap, and American Homes 4 Rent Class A pays a 3.88% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | AMH | |
|---|---|---|
Market Cap | $3.33B | $12.23B |
Sector | Health | Real Estate |
52-Week High | $22.37 | $36.74 |
52-Week Low | $10.24 | $27.38 |
Enterprise Value | $3.19B | $17.32B |
Dividend Yield | — | 3.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADPT trades at $20.82, down 1.75% today, with a bullish technical signal from moving averages and a consensus analyst price target of $20.40. The company announced a strategic separation of its MRD and Immune Medicine businesses in June 2026, alongside a $300 million convertible notes offering to enhance financial flexibility. Revenue grew to $277 million in 2025, though net losses persist at -$59.50 million, with improving margins and cash flow trends showing net positive cash generation of $22.37 million.
Outlook remains cautiously optimistic as the business split aims to unlock value, but execution risks and sustained profitability challenges pose headwinds. Analysts are predominantly bullish (64.71% buy ratings), citing growth in the clonoSEQ MRD segment, yet the stock faces volatility from high valuation multiples and insider selling activity.
AMH trades at $34.00, down 0.23% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $35.41. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.35 exceeding expectations of $0.1763. Revenue grew to $1.85 billion in 2025, with a net income margin of 25.27%, while the stock trades at a P/E of 27.45 and P/S of 6.69. A dividend of $0.33 per share is scheduled for payment on June 30, 2026.
AMH presents a positive outlook driven by consistent earnings performance and robust fundamentals, though elevated valuation ratios and high debt levels pose risks. Investor sentiment is supported by bullish analyst ratings and strong occupancy rates in the single-family rental market, but macroeconomic factors and interest rate sensitivity remain key considerations for potential investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About American Homes 4 Rent Class A
American Homes 4 Rent is a real estate investment trust primarily focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's largest geographical markets include Dallas, Texas
Read more on AMH →
